- Home
- CMMB vs CNVS Comparison
CMMB vs CNVS Comparison
Compare CMMB & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- CNVS
- Stock Information
- Founded
- CMMB 2004
- CNVS 2000
- Country
- CMMB Israel
- CNVS United States
- Employees
- CMMB N/A
- CNVS N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- CNVS Consumer Electronics/Video Chains
- Sector
- CMMB Health Care
- CNVS Consumer Discretionary
- Exchange
- CMMB Nasdaq
- CNVS Nasdaq
- Market Cap
- CMMB 27.0M
- CNVS 22.8M
- IPO Year
- CMMB N/A
- CNVS 2003
- Fundamental
- Price
- CMMB $1.60
- CNVS $3.75
- Analyst Decision
- CMMB Strong Buy
- CNVS Buy
- Analyst Count
- CMMB 3
- CNVS 1
- Target Price
- CMMB $7.33
- CNVS $10.00
- AVG Volume (30 Days)
- CMMB 119.1K
- CNVS 516.6K
- Earning Date
- CMMB 11-14-2024
- CNVS 11-14-2024
- Dividend Yield
- CMMB N/A
- CNVS N/A
- EPS Growth
- CMMB N/A
- CNVS N/A
- EPS
- CMMB N/A
- CNVS N/A
- Revenue
- CMMB N/A
- CNVS $45,005,000.00
- Revenue This Year
- CMMB N/A
- CNVS $31.52
- Revenue Next Year
- CMMB N/A
- CNVS N/A
- P/E Ratio
- CMMB N/A
- CNVS N/A
- Revenue Growth
- CMMB N/A
- CNVS N/A
- 52 Week Low
- CMMB $0.42
- CNVS $0.72
- 52 Week High
- CMMB $2.55
- CNVS $4.17
- Technical
- Relative Strength Index (RSI)
- CMMB 52.53
- CNVS 76.94
- Support Level
- CMMB $1.54
- CNVS $2.48
- Resistance Level
- CMMB $1.73
- CNVS $3.96
- Average True Range (ATR)
- CMMB 0.16
- CNVS 0.38
- MACD
- CMMB 0.01
- CNVS 0.09
- Stochastic Oscillator
- CMMB 45.45
- CNVS 100.00
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).